Presentation

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

Presenter: Andreas Baumbach

May 25, 2018

REGISTER for free or LOG IN to view this content

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

Coronary

DES/BRS/DCB

Presentation

EuroPCR 2018

TARGET AC

Up Next

Presentation

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

Presenter: Tuomas Rissanen

May 26, 2018

More slides +

Presentation

Manual vs Mechanical Compression of Radial Artery After Transradial Coronary Angiography

June 05, 2018

Presentation

High-Sensitivity Troponins and Outcomes After MI

June 06, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.